Inhibitori PD-1/PD-L1

Clasificare ATC · grupa L01FF

Atezolizumab

TECENTRIQ 1200 mg

ATEZOLIZUMAB ◾ 1200mg/20ml ◾ CONC. PT. SOL. PERF.

C2

PNS

TECENTRIQ 1875 mg

ATEZOLIZUMAB ◾ 1875mg/15ml ◾ SOL. INJ.

C2

PNS

Avelumabum

BAVENCIO 20 mg/ml

AVELUMABUM ◾ 20mg/ml ◾ CONC. PT. SOL. PERF.

C2

PNS

Cemiplimabum

CEMIPLIMABUM ◾ 50mg/ml ◾ CONC. PT. SOL. PERF.

C2

PNS

Durvalumabum

IMFINZI 50 mg/ml

DURVALUMABUM ◾ 50mg/ml ◾ CONC. PT. SOL. PERF.

C2

PNS

Nivolumabum

OPDIVO 10 mg/ml

NIVOLUMABUM ◾ 10mg/ml ◾ CONC. PT. SOL. PERF.

C2

PNS

NIVOLUMABUM ◾ 300mg ◾ SOL. INJ.

NIVOLUMABUM ◾ 600mg ◾ SOL. INJ.

Pembrolizumabum

KEYTRUDA 25 mg/ml

PEMBROLIZUMABUM ◾ 25mg/ml ◾ CONC. PT. SOL. PERF.

C2

PNS

KEYTRUDA 395 mg

PEMBROLIZUMABUM ◾ 395mg ◾ SOL INJ.

KEYTRUDA 790 mg

PEMBROLIZUMABUM ◾ 790mg ◾ SOL INJ.

Retifanlimabum

RETIFANLIMABUM ◾ 500mg ◾ CONC. PT. SOL. PERF.

Serplulimabum

HETRONIFLY 10 mg/ml

SERPLULIMABUM ◾ 10mg/ml ◾ CONC. PT. SOL. PERF.

Tislelizumabum

TEVIMBRA 100 mg

TISLELIZUMABUM ◾ 100mg ◾ CONC. PT. SOL. PERF.

Toripalimabum

LOQTORZI 240 mg

TORIPALIMABUM ◾ 240mg ◾ CONC. PT. SOL. PERF.